Unknown PHASE3 INTERVENTIONAL 2-arm NCT01860716

Impact of Melatonin in the Pretreatment of Organ Donor and the Influence in the Evolution of Liver Transplant.

Impact of Melatonin in the Pretreatment of Organ Donor and the Influence in the Evolution of Liver Transplant: a Prospective, Randomised Double-blind Study.

Sponsor: Aragon Institute of Health Sciences

Conditions Evidence of Liver Transplantation

Interventions Melatonin Placebo

Updated 5 times since 2017 Last updated: May 22, 2013 Started: May 31, 2013 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01860716, this PHASE3 trial focuses on Evidence of Liver Transplantation and remains ongoing. Sponsored by Aragon Institute of Health Sciences, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aragon Institute of Health Sciences
Fondo de Investigacion Sanitaria

Data source: Aragon Institute of Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zaragoza, Spain